Title : The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus.

Pub. Date : 2019 Sep 27

PMID : 31402258






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 NTZ significantly inhibits EBOV replication in human cells through its effects on RIG-I and protein kinase R (PKR), suggesting that it counteracts EBOV VP35 protein"s ability to block RIG-I and PKR sensing of EBOV. nitazoxanide eukaryotic translation initiation factor 2 alpha kinase 2 Homo sapiens
2 NTZ significantly inhibits EBOV replication in human cells through its effects on RIG-I and protein kinase R (PKR), suggesting that it counteracts EBOV VP35 protein"s ability to block RIG-I and PKR sensing of EBOV. nitazoxanide eukaryotic translation initiation factor 2 alpha kinase 2 Homo sapiens
3 NTZ significantly inhibits EBOV replication in human cells through its effects on RIG-I and protein kinase R (PKR), suggesting that it counteracts EBOV VP35 protein"s ability to block RIG-I and PKR sensing of EBOV. nitazoxanide eukaryotic translation initiation factor 2 alpha kinase 2 Homo sapiens